David L. Lowrance has been promoted to Vice President and Chief FinancialOfficer. In this role, he is responsible for overseeing the company'saccounting and financial activities, including financial reporting andplanning. Mr. Lowrance has 17 years of financial and accounting experience,joining Cumberland in 2003 as Director of Finance and Accounting. He spenteight years with two global conglomerates, including four years as senior vicepresident for Icore International. Prior to this, Mr. Lowrance spent fouryears at Ernst & Young, LLP. A graduate of the University of Georgia, he is acertified public accountant.
Advertisement
Doug Jack has joined the company as Senior Manager of SEC Reporting. He isresponsible for the preparation of all SEC-required financial reports. Mr.Jack brings more than 14 years of accounting and financial experience to hisposition. Prior to joining Cumberland, he spent eight years as audit managerwith Ernst & Young and PricewaterhouseCoopers, and served as CFO andcontroller at Southern Specialty Brands. A certified public accountant, he isa graduate of the University of Georgia.
Advertisement
"We are fortunate to work with these outstanding individuals who bringgreat depth of experience and knowledge in their respective areas," said A.J.Kazimi, Cumberland's Chief Executive Officer. "Each will play an importantrole in taking the company to the next level as we continue to grow andcapitalize on opportunities created by the shifting pharmaceutical landscape."
About Cumberland Pharmaceuticals Inc.
Cumberland Pharmaceuticals Inc. is a Tennessee-based specialtypharmaceutical company focused on the acquisition, development andcommercialization of branded prescription products. Cumberland's primarytarget markets include hospital acute care and gastroenterology. Cumberlandmarkets Acetadote(R) for the treatment of acetaminophen poisoning andKristalose(R), a prescription strength laxative. The Company is alsodeveloping Amelior(R) which is in Phase III studies for the treatment of bothpain and fever. Cumberland is dedicated to providing innovative products whichimprove quality of care for patients.
SOURCE Cumberland Pharmaceuticals Inc.
